A clinical trial has found evidence that the experimental drug tofersen lowers levels of a disease-causing protein in people with an inherited form of amyotrophic lateral sclerosis, or ALS, caused by mutations in the gene SOD1.
from Latest Science News -- ScienceDaily https://ift.tt/2VZTQDU
via IFTTT
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment